These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35603567)

  • 1. Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study.
    Zhong S; Zhang Z; Guo Z; Yang W; Dou G; Lv X; Wang X; Ge J; Wu B; Pan X; Wang H; Mou Y
    Bioengineered; 2022 May; 13(5):12003-12020. PubMed ID: 35603567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the inhibitory behavior of XFE and mitoxantrone molecules in interaction with AKT1 protein: a molecular dynamics simulation study.
    Amiran MR; Taghdir M; Abasi Joozdani F
    J Mol Model; 2023 Apr; 29(5):153. PubMed ID: 37086344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
    Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
    Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sharif Siam MK; Sarker A; Sayeem MMS
    J Biomol Struct Dyn; 2021 Oct; 39(17):6467-6479. PubMed ID: 32746771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel mycocompounds as inhibitors of PI3K/AKT/mTOR pathway against RCC.
    Yadav RP; Chatterjee S; Chatterjee A; Pal DK; Ghosh S; Acharya K; Das M
    J Recept Signal Transduct Res; 2022 Dec; 42(6):599-607. PubMed ID: 36125981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
    Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
    J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling.
    Wang B; Zhang X; Li ZS; Wei C; Yu RZ; Du XZ; He YJ; Ren Y; Zhen YW; Han L
    Cancer Lett; 2024 Mar; 585():216665. PubMed ID: 38290657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Epipachysamine B suppresses proliferation and induces apoptosis of breast cancer cell via PI3K/AKT/mTOR signaling pathway.
    Zhang L; Zheng Y; Zeng L; Zhang F; Che D; Cao Z; Huang C; Xian L; Zhang X; Zhang H; Guo Z
    Life Sci; 2021 Nov; 285():119995. PubMed ID: 34592228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of allosteric inhibitor against AKT1 through structure-based virtual screening.
    Karunakaran K; Muniyan R
    Mol Divers; 2023 Dec; 27(6):2803-2822. PubMed ID: 36522517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities.
    Li T; Wang G
    Int J Mol Sci; 2014 Oct; 15(10):18856-91. PubMed ID: 25334061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual Screening of Natural Compounds as Potential PI
    Dotolo S; Cervellera C; Russo M; Russo GL; Facchiano A
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New in-capillary electrophoretic kinase assays to evaluate inhibitors of the PI3k/Akt/mTOR signaling pathway.
    Nehmé R; Nehmé H; Saurat T; de-Tauzia ML; Buron F; Lafite P; Verrelle P; Chautard E; Morin P; Routier S; Bénédetti H
    Anal Bioanal Chem; 2014 Jun; 406(15):3743-54. PubMed ID: 24817345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.
    Politz O; Siegel F; Bärfacker L; Bömer U; Hägebarth A; Scott WJ; Michels M; Ince S; Neuhaus R; Meyer K; Fernández-Montalván AE; Liu N; von Nussbaum F; Mumberg D; Ziegelbauer K
    Int J Cancer; 2017 Jan; 140(2):449-459. PubMed ID: 27699769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
    Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
    Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.
    Ajjarapu SM; Tiwari A; Taj G; Singh DB; Singh S; Kumar S
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):68. PubMed ID: 34727985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.
    Zhang C; Yang N; Yang CH; Ding HS; Luo C; Zhang Y; Wu MJ; Zhang XW; Shen X; Jiang HL; Meng LH; Ding J
    PLoS One; 2009; 4(3):e4881. PubMed ID: 19293927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening.
    Yilmaz OG; Olmez EO; Ulgen KO
    Comput Biol Chem; 2014 Feb; 48():1-13. PubMed ID: 24291487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt Serine/Threonine Kinase 1 Regulates de Novo Fatty Acid Synthesis through the Mammalian Target of Rapamycin/Sterol Regulatory Element Binding Protein 1 Axis in Dairy Goat Mammary Epithelial Cells.
    Zhang T; Huang J; Yi Y; Zhang X; Loor JJ; Cao Y; Shi H; Luo J
    J Agric Food Chem; 2018 Feb; 66(5):1197-1205. PubMed ID: 29323924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.